First High-Quality Study to Explore A Carnivore-Style Diet in Managing Metabolic Health, WhichAffects Millions of AmericansOver one-third of U.S. adults – or 115.2 million Americans – are prediabetic, ...
In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...
MedPage Today on MSN
Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
MedPage Today on MSN
Pre-Op Chemo or Upfront Surgery in Colon Cancer: Is One Strategy Best?
"Optimal regimens and ideal patients remain undefined," experts say ...
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...
A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194. This is an ASCO Meeting Abstract from the ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results